Rayonier Advanced Materials, Inc.

As of September 11, 2025, Rayonier Advanced Materials, Inc. shows a neutral technical trend with mixed signals, including a bullish weekly MACD and bearish monthly MACD, while the stock has outperformed the S&P 500 in the short term but underperformed year-to-date.

As of November 7, 2023, Rayonier Advanced Materials, Inc. is considered risky due to its negative P/E ratio and low ROE, despite a recent 1-month return of 38.72%, as its overall financial health raises concerns compared to peers like Westlake Chemical Partners LP, which is rated very attractive.

As of November 7, 2023, Rayonier Advanced Materials, Inc. is considered risky and overvalued with a Price to Book Value of 0.38 and a negative ROE of -1.34%, contrasting sharply with peers like Proto Labs and Westlake Chemical Partners, and has a year-to-date return of -53.70% compared to the S&P 500's 2.44%.

As of May 7, 2025, Rayonier Advanced Materials, Inc. is in a bearish trend with moderate strength, indicated by bearish daily moving averages, weekly Bollinger Bands, a bearish MACD on a monthly basis, and a mildly bearish OBV trend.

As of March 2022, the management team of Rayonier Advanced Materials, Inc. includes Mr. DeLyle Bloomquist (Non-Executive Chairman), Mr. Paul Boynton (President and CEO), and five independent directors: Mr. Charles Adair, Ms. Julie Dill, Mr. James Kirsch, and Mr. David Mariano. They are responsible for the company's strategic direction and governance.

Rayonier Advanced Materials, Inc. produces cellulose specialties in the specialty chemicals industry and has a market cap of $259.09 million. As of March 2025, it reported net sales of $356 million and a net loss of $32 million.

As of Jun 18, Rayonier Advanced Materials, Inc. has a market capitalization of 259.09 million, with net sales of 1,598.12 million and a net profit of -72.38 million over the latest four quarters.